Musculoskeletal Disorders Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Musculoskeletal Disorders Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global musculoskeletal disorders drugs market is expected to grow at a CAGR of around 6.5% during 2025-2034. This report on global musculoskeletal disorders drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global musculoskeletal disorders drugs market by segmenting the market based on type, route of administration, distribution channel and region. Also, detailed profiles of companies operating in the musculoskeletal disorder’s drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Incidences and Prevalence of Musculoskeletal Disorders

Market Challenges

• Low Access to Treatment

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type

• Analgesics
• Corticosteroids
• DMARDs
• Other Types

Market by Route of Administration

• Oral
• Parenteral

Market by Distribution Channel

• Hospital Pharmacies
• Online Providers
• Drug Stores and Retail Pharmacies

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa


1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Musculoskeletal Disorders Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Musculoskeletal Disorders Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Type
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Musculoskeletal Disorders Drugs Market by Type
5.1. Introduction
5.2. Analgesics
5.3. Corticosteroids
5.4. DMARDs
5.5. Other Types
6. Global Musculoskeletal Disorders Drugs Market by Route of Administration
6.1. Introduction
6.2. Oral
6.3. Parenteral
7. Global Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Providers
7.4. Drug Stores and Retail Pharmacies
8. Global Musculoskeletal Disorders Drugs Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. AbbVie Inc.
12.2.2. Amgen Inc.
12.2.3. AstraZeneca plc
12.2.4. Bristol-Myers Squibb Company
12.2.5. Eli Lilly and Company
12.2.6. GlaxoSmithKline plc
12.2.7. Johnson & Johnson
12.2.8. Merck & Co., Inc.
12.2.9. Novartis AG
12.2.10. Pfizer Inc.
12.2.11. Roche Holding AG
12.2.12. Sanofi S.A.
List of Figures
Figure 1: Global Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 2: Global Musculoskeletal Disorders Drugs Market by Type, 2024
Figure 3: Global Musculoskeletal Disorders Drugs Market by Route of Administration, 2024
Figure 4: Global Musculoskeletal Disorders Drugs Market by Distribution Channel, 2024
Figure 5: Global Musculoskeletal Disorders Drugs Market by Region, 2024
Figure 6: Global Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 7: Global Musculoskeletal Disorders Drugs Market by Type (in %), 2024 & 2034
Figure 8: Global Analgesics Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 9: Global Analgesics Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 10: Global Corticosteroids Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 11: Global Corticosteroids Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 12: Global DMARDs Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 13: Global DMARDs Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 14: Global Other Types Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 15: Global Other Types Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 16: Global Musculoskeletal Disorders Drugs Market by Route of Administration (in %), 2024 & 2034
Figure 17: Global Oral Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 18: Global Oral Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 19: Global Parenteral Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 20: Global Parenteral Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 21: Global Musculoskeletal Disorders Drugs Market by Distribution Channel (in %), 2024 & 2034
Figure 22: Global Hospital Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 23: Global Hospital Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 24: Global Online Providers Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 25: Global Online Providers Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 26: Global Drug Stores and Retail Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 27: Global Drug Stores and Retail Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 28: Global Musculoskeletal Disorders Drugs Market by Region (in %), 2024 & 2034
Figure 29: Europe Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 30: Europe Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 31: Europe Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
Figure 32: Germany Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 33: United Kingdom Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 34: France Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 35: Italy Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 36: Spain Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 37: Russia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 38: Netherlands Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 39: North America Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 40: North America Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 41: North America Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
Figure 42: United States Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 43: Canada Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 44: Asia Pacific Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 45: Asia Pacific Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 46: Asia Pacific Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
Figure 47: China Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 48: Japan Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 49: India Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 50: South Korea Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 51: Australia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 52: Indonesia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 53: Latin America Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 54: Latin America Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 55: Latin America Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
Figure 56: Mexico Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 57: Brazil Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 58: Argentina Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 59: Middle East & Africa Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
Figure 60: Middle East & Africa Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
Figure 61: Middle East & Africa Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
Figure 62: Saudi Arabia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 63: Turkey Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 64: Iran Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 65: UAE Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
Figure 66: Market Value Chain
List of Tables
Table 1: Global Musculoskeletal Disorders Drugs Market Portraiture
Table 2: Global Musculoskeletal Disorders Drugs Market by Type (in US$ Million), 2024 & 2034
Table 3: Global Musculoskeletal Disorders Drugs Market by Route of Administration (in US$ Million), 2024 & 2034
Table 4: Global Musculoskeletal Disorders Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 5: Global Musculoskeletal Disorders Drugs Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Musculoskeletal Disorders Drugs Market by Country (in US$ Million),
2024 & 2034
Table 11: List of Key Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings